Curettage Versus Excision in Nodular and Superficial Basal Cell Carcinomas
NCT00515970 · Status: SUSPENDED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 400
Last updated 2010-06-15
Summary
Basal cell carcinoma (BCC) is the most frequent skin cancer. Uncontrolled growth destroys local anatomic structures. There are various treatment alternatives with different recurrence rates and expenses. After surgical excision, the recurrence rate is in between 3 and 4% and the procedure is relatively expensive. Photodynamic therapy as well as imiquimod 5% are expensive therapies with high recurrence rates, that lack histologic evidence of BCC. Cryosurgery and curettage are inexpensive, although the recurrence rates are higher than after surgical excision.
This prospective, randomized trial compares recurrence rates, cosmetic outcome, and surgery-related complications after curettage versus surgical excision in nodular and superficial BCC. About 600 tumors will be included. One half is treated by curettage, the other half by surgical excision. The follow-up period is four years. If the difference between recurrence rates is ≤7% and the cosmetic outcome as well as the surgery-related complications are not worse after curettage, surgical excision must be considered an overtreatment.
Conditions
- Carcinoma, Basal Cell
Interventions
- PROCEDURE
-
Curettage
Curettage without subcutaneous tissue using a 7 mm ring curette and the "fountain-pen technique" (http://www.biopsypunch.com/kuerettagetechnik.htm; accessed on March 13, 2008). The curette is held between the thumb, index and middle finger. This method of holding enables precise guiding of the instrument, so that the piece of tissue can be removed in one well-targeted incision. After macroscopically complete removal, a safety margin is removed with the curette. It is used for histology to distinguish between R0 (excision margin without tumor cells) and R1 resection (excision margin containing tumor cells). Preparation with paraffin. Parallel, vertical sections for histologic diagnosis. Hematoxylin-eosin staining. Measurement of tumor thickness in mm.
- PROCEDURE
-
Deep excision
12 o'clock mark. Excision with a scalpel down to the subcutaneous level. Plastic reconstruction. Three vertical, parallel bread loaf sections for histology. Preparation with paraffin. Staining with hematoxylin-eosin. Histologic diagnosis including report of tumor thickness in mm. Comment on complete removal (R0 versus R1). In case of R1 excision directed reoperations are performed until R0 is achieved.
- PROCEDURE
-
Shave excision
Shave excision with a safety margin, using a scalpel. Wound healing by secondary intention. Preparation with paraffin. Parallel vertical bread loaf sections for histology. Staining with hematoxylin-eosin. Histologic diagnosis. Comment on complete removal (R0 versus R1). In case of R1 excision a reoperation is performed until R0 is achieved.
- PROCEDURE
-
Curettage
Curettage with a 7 mm ring curette with the "potato-peeler technique" (http://www.biopsypunch.com/kuerettagetechnik.htm; accessed on March 13, 2008). The handle of the curette is held in the distal inter-digital fold of the index finger, and supported by the other fingers of the curetting hand. The thumbs serve to provide a stable base. This technique makes it possible to guide the instrument, applying greater pressure, but accuracy is reduced. After macroscopically complete removal, a safety margin is removed with the curette. It is used for histology to distinguish between R0 (excision margin without tumor cells) and R1 resection (excision margin containing tumor cells). Preparation with paraffin. Parallel, vertical sections for histologic diagnosis. Hematoxylin-eosin staining.
Sponsors & Collaborators
-
University Hospital Tuebingen
lead OTHER
Principal Investigators
-
Helmut Breuninger, M.D. · Department of Dermatology, Eberhard Karls University Tuebingen
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2007-12-31
- Primary Completion
- 2014-12-31
- Completion
- 2014-12-31
Countries
- Germany
Study Locations
More Related Trials
-
Basal Cell Carcinoma Recurrence After Mohs Surgery
NCT00882791 ·Status: COMPLETED
-
New Versus Approved Methyl-aminolevulinate Photodynamic Therapy (MAL-PDT) Regime in Basal Cell Carcinoma (BCC)
NCT01482104 ·Status: COMPLETED ·Phase: NA
-
Study Evaluating the Efficacy of Oral Vismodegib in Various Histologic Subtypes
NCT01700049 ·Status: COMPLETED ·Phase: PHASE2
-
Mohs Versus Traditional Surgery - Basal-Cell Carcinomas (BCC)
NCT00699829 ·Status: UNKNOWN
-
Vismodegib on Locally Advanced Basal Cell Carcinoma Under Real World Conditions
NCT02781389 ·Status: COMPLETED
-
MoleGazer Development Feasibility Study
NCT05015816 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
DMSO-PDT of BCC - A 6 Year Follow up
NCT00218829 ·Status: COMPLETED
-
Impact of Excision Margins on Survival and Recurrence Rate in Patients With Thick Melanoma (>2mm)
NCT02088762 ·Status: COMPLETED
-
Rates of Positive Basal Cell Carcinomas (BCCs) in Re-excisions
NCT01403480 ·Status: COMPLETED
-
Fast Track Diagnosis of Skin Cancer by Advanced Imaging
NCT04229277 ·Status: COMPLETED ·Phase: NA
-
Added Value of OCT for Diagnosing Recurrent BCC After Non-invasive Treatment
NCT05581342 ·Status: COMPLETED ·Phase: NA
-
Vismodegib in Treating Patients With Basal Cell Carcinoma (BCC)
NCT01631331 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Complications and Recurrences After Mohs Micrographic Surgery and Slow Mohs
NCT06014619 ·Status: ACTIVE_NOT_RECRUITING
-
The Impact of Total Body Skin Examination on Skin Cancer Detection
NCT00765193 ·Status: COMPLETED ·Phase: NA
-
To Assess The Efficacy And Safety Of Vismodegib And Radiotherapy In Advanced Basal Cell Carcinoma
NCT02956889 ·Status: TERMINATED ·Phase: PHASE2
-
Real-world Evaluation of Diagnostic and Treatment Strategies in Low-Risk Basal Cell Carcinoma
NCT06252857 ·Status: RECRUITING
-
A Comparison of Skin Grafts Versus Local Flaps for Facial Skin Cancer From the Patient Perspective: A Feasibility Study
NCT04805905 ·Status: UNKNOWN
-
Autologous Patch Healing vs. Secondary Intention Healing After Mohs Micrographic Surgery
NCT05170035 ·Status: UNKNOWN ·Phase: NA
-
Comparative Retrospective Analysis of Skin Tumors of the Eyelids and Face in 2 Brussels University Hospitals Over 5 Years in Dermatology or Ophthalmology
NCT04886908 ·Status: COMPLETED
-
Feasibility and Functionality of fPAM Imaging in Melanoma
NCT00776945 ·Status: TERMINATED
-
TOtal Skin Electron Beam Therapy (Low-dose) for Tumor Clone Eradication in Early-stage Mycosis Fungoides
NCT05205902 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Reflectance Confocal Microscopy in Basal Cell Carcinoma
NCT02623101 ·Status: COMPLETED ·Phase: NA
-
Complete Lymph Node Dissection vs Watchful Waiting in Patients With Malignant Melanoma (Thickness of 1,0mm+ and Evidence of Metastases in the Sentinel Node)
NCT02434107 ·Status: COMPLETED ·Phase: NA
-
L19IL2/TNF in Patients With Basal Cell Carcinoma
NCT07227870 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Patient Reported Outcome Measures After Treatment of Skin Cancers on the Face
NCT04485442 ·Status: ACTIVE_NOT_RECRUITING